14
FUNAHASHI, H.; STUMPF, T.T.; CANTELY, T.C.; KIN, N.H.; DAY, B.N. Pronuclear
formation and intracellular glutathione content of in vitro matured porcine oocytes
following in vitro fertilization and/or electrical activation. Zigote, v. 3, p. 273-281, 1995.
GORDON, I. Laboratory production of cattle embryos. Cambridge: Cambridge
University Press, 1994. p. 30-142.
GOSDEN, R.; KRAPEZ, J.;BRIGGS, D. Growth and development of the mammalian
oocyte. BioEssays, v. 19, p. 875-882, 1997.
HALL, A.G. The role of glutathione in the regulation of apoptosis. European Journal of
Clinical Investigation, v. 29, p. 238-245, 1999.
HE, C.L.; DAMIANI, P.; PARYS, J.B.; FISSORE, R.A. Calcium, calcium release
receptors, and meiotic resumption in bovine oocytes. Biology of Reproduction, v. 57,
p. 1245-1255, 1997.
HELMA, C.; UHL, M. A public domain image-analysis program for the single-cell gel-
electrophoresis (comet) assay. Mutation Research, v. 466, p. 9-15, 2000.
HYSLOP, P.A.; HINSHAW, D.B.; HALSEY, W.A.Jr.; SCHRAUFSTATTER, I.U.;
SAUERHEBER, R.D.; SPRAGG, R.G.; JACKSON, J.H.; COCHRANE, C.G.
Mechanisms of oxidant-mediated cell injury. The glycolytic and mitochondrial pathways
of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide.
Journal of Biological Chemistry, v. 263, p. 1665-1675, 1988.
HYTTEL, P.; FAIR, T.; CALLESEN, H.; GREVE, T. Oocyte growth, capacitation and final
maturation in cattle. Theriogenology, v. 47, p. 23-32, 1997.
KASTROP, P.M.M.; BEVERS, M.M.; DESTREE, O.H.J.; KRUIP, T.A.M. Changes in
protein synthesis and phosphorylation patterns during bovine oocyte maturation in vitro.
Journal of Reproduction and Fertility, v. 90, p. 305-310, 1990.
KASTROP, P.M.M.; HULSHOF, S.C.J.; BEVERS, M.M.; DESTREE, O.H.J.; KRUIP,
T.A.M. The effects of aamanitin and cycloheximide on nuclear progression, protein
synthesis, and phosphorylation during bovine oocyte maturation in vitro. Molecular
Reproduction and Development, v. 28, p. 249-254, 1991.
KERR, J.F.; SEARLE, J. The digestion of cellular fragments within phagolysosomes in
carcinoma cells. Journal of Pathology, v. 108, p. 55-8, 1972.
KITAGAWA, M.; OKABE, T.; OGINO, H.; MATSUMOTO, H.; SUZUKI-TAKAHASHI, I.;
KOKUBO, T.; HIGASHI, H.; SAITOH, S; TAYA, Y; YASUDA, H.; OHBA, Y.;
NISHIMURA, S.; TANAKA, N.; OKUYAMA, A. Butyrolactone I, a selective inhibitor of
cdk2 and cdc2 kinase. Oncogene, v. 8, p. 2425-2432, 1993.